HPV genotyping in adenocarcinoma of the uterine cervix in Thailand

被引:7
|
作者
Siriaunkgul, Sumalee [1 ]
Utaipat, Utaiwan [2 ]
Suthipintawong, Cheepsumon [3 ]
Tungsinmunkong, Kobkul [4 ]
Triratanachat, Surang [5 ]
Khunamornpong, Surapan [1 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50200, Thailand
[3] Rajavithi Hosp, Dept Pathol, Bangkok, Thailand
[4] Prince Songkla Univ, Fac Med, Dept Pathol, Hat Yai, Songkhla, Thailand
[5] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand
关键词
Adenocarcinoma; Genotyping; Human papillomavirus; Prevalence; Uterine cervix; HUMAN-PAPILLOMAVIRUS DNA; HISTOLOGICAL SUBTYPES; NORTHERN THAILAND; UNITED-STATES; RISK-FACTORS; PREVALENCE; CANCER; WORLDWIDE; PCR; METAANALYSIS;
D O I
10.1016/j.ijgo.2013.06.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the distribution of human papillomavirus (HPV) genotypes in cervical adenocarcinoma in Thailand and to evaluate the clinicopathologic characteristics associated with common HPV genotypes. Methods: Formalin-fixed, paraffin-embedded tissues from 150 patients with adenocarcinoma were collected from 4 areas of Thailand. Infection with HPV was detected by nested polymerase chain reaction (PCR) with primers MY09/11 and GP5+/6+. Genotyping was performed using a linear array assay, followed by type-specific PCR targeting the E6/E7 regions of HPV-16, HPV-18, and HPV-52 if the linear array test was negative. Results: Human papillomavirus DNA was detected in 145 (97%) adenocarcinomas (132 single infections; 11 multiple infections; 2 tumors with undetermined HPV type). Genotype 18 was most common (66%), followed by HPV-16 (30%) and HPV-45 (3%). Infection with only HPV-16 and/or HPV-18 accounted for 88% of the HPV-positive tumors. Patients with HPV-18 infection had a younger age (P = 0.009) and higher tumor grade (P < 0.001) than patients with HPV-16 infection. Conclusion: The HPV detection rate in cervical adenocardnomas in Thailand is high. The predominant genotype is HPV-18, being twice as common as HPV-16. Genotype variations are associated with patient age and tumor grade. Vaccination against HPV-16/HPV-18 might prevent almost 90% of adenocarcinomas. (C) 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:226 / 230
页数:5
相关论文
共 50 条
  • [1] HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand
    Siriaunkgul, Sumalee
    Utaipat, Utaiwan
    Settakorn, Jongkolnee
    Sukpan, Kornkanok
    Srisomboon, Jatupol
    Khunamornpong, Surapan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (02) : 175 - 179
  • [2] HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix
    Quint, Koen D.
    de Koning, Maurits N. C.
    van Doorn, Leen-Jan
    Quint, Wim G. V.
    Pirog, Edyta C.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 297 - 301
  • [3] HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix
    Baalbergen, Astrid
    Smedts, Frank
    Ewing, Patricia
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Helmerhorst, Theo J. M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 530 - 534
  • [4] A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA
    Zhua, Cairong
    Bassig, Bryan A.
    Zhang, Yawei
    Shi, Kunchong
    Boyle, Peter
    Li, Ni
    Zheng, Tongzhang
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2015, 24 (03) : 240 - 244
  • [5] Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix
    Machida, Hiroko
    Matsuo, Koji
    Matsuzaki, Shinya
    Yamagami, Wataru
    Ebina, Yasuhiko
    Kobayashi, Yoichi
    Tabata, Tsutomu
    Kaneuchi, Masanori
    Nagase, Satoru
    Enomoto, Takayuki
    Mikami, Mikio
    CANCERS, 2020, 12 (05)
  • [6] Detection and genotyping of human papillomavirus in biopsies of uterine cervical adenocarcinoma
    Brebi M, Priscilla
    Gloria Ili G, Carmen
    Lopez M, Jaime
    Garcia M, Patricia
    Melo A, Angelica
    Montenegro H, Sonia
    Leal R, Pamela
    Guzman G, Pablo
    Carlos Roa S, Juan
    REVISTA MEDICA DE CHILE, 2009, 137 (03) : 377 - 382
  • [7] Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix
    Kim, Ha-Jeong
    Sung, Ji-Hee
    Lee, Eunjung
    Ahn, Soomin
    Song, Sang Yong
    Choi, Chel Hun
    Kim, Tae-Joong
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Lee, Jeong-Won
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (07) : 1299 - 1305
  • [8] The Analysis and Clinical Usefulness of HPV DNA Chip Test in the Uterine Cervix
    Jeong, Joo Hyeon
    Cho, Hyun Yee
    Kim, Na Rae
    Chung, Dong Hae
    Park, Sanghui
    Ha, Seung Yeon
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 77 - 82
  • [9] Diagnostic pitfalls in minimal deviation adenocarcinoma of the uterine cervix: Review and update
    Mardi, Kavita
    CLINICAL CANCER INVESTIGATION JOURNAL, 2021, 10 (06): : 269 - 274
  • [10] Focus on mucinous adenocarcinoma of the uterine cervix
    Bonin, L.
    Devouassoux-Shisheboran, M.
    Golfier, F.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (04): : 352 - 361